Sprint Bioscience AB (publ)

kr 4.00As of Sun 8 Nov 2026, 12:00 UTC
STO:SPRINTHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (19.16%)
Div yield —
ROE 144.94%
Biotechnology
Beta (5Y) (0.63)
PE TTM 5.658
TSR TTM 473.07%
Mkt cap kr 422.1M
ROIC 94.48%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 5.02
25.52%
177.13%
Hold 5|4|7|1|10
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.06
0.06
0.06
0.06
26.20%
24.53%
18.33%
16.39%
Revenuekr M
41.18
43.44
42.90
43.28
3.94%
11.89%
7.74%
3.93%
Peers (US$42.67M)
Cap (US$)
PE
45.75M
2.402x
Capital
TTM
5Y
10Y
Leveragex
0.707
2.661
2.499
EBIT/Intx
12.53
2.079
1.493
Own earn%
35.16
(70.04)
(71.36)
Sh yield%
27.34
31.14
31.19
Owners
Insiders/Inst%
12.27
36.85
Short interest%
5.95
SBC / revenue%
4.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
0
Op margin range%
26–35
$1 testx
0.1
Incr. ROIC%
19